CXCL1 and cancer: With regard to up-regulated DEGs enriched in immune response, it is now well-established that FGR, CXCL1, NLRC4 and S100A9 influence the pathogenesis of cancer by modulating immune responses and promoting progression, aggressiveness and cell survival 32-35.